<DOC>
	<DOCNO>NCT02127515</DOCNO>
	<brief_summary>This randomize controlled trial woman risk follow combine prenatal screen Down Syndrome . Women ask preference NIPT routine prenatal diagnosis base dedicated questionnaire . Women randomize NIPT standard invasive prenatal diagnosis .</brief_summary>
	<brief_title>Non Invasive Prenatal Testing Down Syndrome</brief_title>
	<detailed_description>This randomize controlled trial woman risk follow combine prenatal screen Down Syndrome . Women ask preference NIPT routine prenatal diagnosis base dedicated questionnaire . Women randomize NIPT standard invasive prenatal diagnosis . The general objective : - Promote rapid large implementation Non Invasive Prenatal Testing ( NIPT ) Down syndrome . - Improve management woman risk combine first trimester screen reduce number invasive procedure induce miscarriage . - Evaluate NIPT medically ( reduce rate invasive sampling related complication , diagnostic performance feasibility acceptability routine practice ) base cost-analysis comparison standard invasive prenatal diagnosis currently propose . - Clarify condition implementation dissemination NIPT overall organization prenatal screen trisomy 21 ( provide data later adjust combination test threshold ) . Promote organization network professional involve prenatal screen trisomy 21 order allow emergence national system collection outcomes improve quality practice The main judgement criterion : - Main : - Percentage fetal loss group - Secondary : - Percentage invasive test group ( amniocentesis chorionic villus sample ) - Diagnostic performance NIPT , particular false positive negative - Percentage result within 3 week average time interval result NIPT - Percentage inconclusive result DPANI - Percentage anomaly discover invasive sample - Percentage invasive sample take despite normal NIPT ( either later ultrasound anomaly maternal reinsurance ) - Association maternal characteristic ( weight , height , parity , previous history , serum marker ... ) result NIPT - Cost analysis NIPT routine clinical practice The study include 2450 high risk woman order power enough detect 1 % reduction miscarriage group undergo NIPT instead routine invasive prenatal diagnosis .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<criteria>pregnant woman 18 risk Down syndrome &gt; 1/250 base combine screen use ultrasound together maternal serum marker prior fetal karyotyping singleton pregnancy pregnancy 11SA et 18SA willing fetal karyotype risk Down syndrome &lt; 1/250 &gt; 1/5 NT &gt; 3 mm , PAPPA beta HCG &lt; 0.3 MoM &gt; 5 MoM multiple pregnancy , vanish twin morphological abnormality US Kown chromosomal anomaly parent Patients willing fetal karyotype</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Down , trisomy 21</keyword>
	<keyword>NIPT</keyword>
	<keyword>Amniocentesis</keyword>
	<keyword>miscarriage</keyword>
	<keyword>invasive</keyword>
	<keyword>prenatal</keyword>
	<keyword>screening .</keyword>
</DOC>